Related Experiment Video
Updated: Jun 4, 2026
12:45
Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
Cardiac resynchronization therapy in the elderly: a realistic option for an increasing population?
Natália António1, Luís Elvas, Lino Gonçalves
1Cardiology Department, Coimbra University Hospital and Medical School, Portugal. natalia.antonio@gmail.com
International Journal of Cardiology
|February 22, 2011
Summary
Cardiac resynchronization therapy (CRT) offers heart failure benefits, but its effectiveness in elderly patients requires careful evaluation. This review examines CRT
Area of Science:
- Cardiology
- Geriatrics
- Medical Devices
Background:
- Heart failure predominantly affects the elderly population.
- Cardiac resynchronization therapy (CRT) is a key treatment for heart failure.
- Concerns exist regarding the efficacy of CRT in older individuals.
Purpose of the Study:
- To review the current data on CRT in elderly patients.
- To assess the efficacy, safety, and indications of CRT in this demographic.
- To explore the influence of comorbidities on CRT outcomes in the elderly.
Main Methods:
- Literature review of existing studies on CRT in elderly heart failure patients.
- Analysis of data focusing on clinical outcomes, adverse events, and patient selection.
- Synthesis of evidence regarding the benefits and risks of CRT in older adults.
Main Results:
- Efficacy of CRT in the elderly is variable and influenced by patient selection.
- Safety profile of CRT in the elderly is generally acceptable, but risks may be higher.
- Comorbidities significantly impact CRT response and outcomes in older patients.
Conclusions:
- CRT can be beneficial for selected elderly heart failure patients.
- Careful patient selection and management of comorbidities are crucial for optimal outcomes.
- Further research is needed to refine CRT strategies for the aging heart failure population.
Related Concept Videos
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
01:30Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...